Joseph Lucci

Partner

Philadelphia
T 215.564.8370  |  F 215.568.3439

"Clients are very impressed with him. He is a very good attorney and a smart individual."

— Chambers USA 2014

Joe Lucci focuses his practice on patent litigation in the life sciences and pharmaceutical industries. Joe's IP practice also encompasses prosecution, interferences, due diligence investigations and patent portfolio management. Joe enjoys working where law and business intersect – working closely with the in-house counsel of major chemical and pharmaceutical companies to develop and execute strategies to obtain, protect and enforce their intellectual property. In addition to achieving litigation victories at the district court and appellate levels, Joe has also been lead counsel in numerous inter partes reviews, inter partes reexaminations, ex parte reexaminations, patent interferences and patent reissue proceedings.

Joe has been ranked since 2007 in Chambers USA: America’s Leading Lawyers for Business and is listed in The Best Lawyers in America©. Joe is the managing partner of BakerHostetler's Philadelphia office and formerly served on Woodcock Washburn's Policy Committee.

Select Experience

  • Led a challenge of the agency's position regarding the availability of subpoenas in inter partes reexamination proceedings, including district court proceedings and an appeal to the Federal Circuit.
  • Secured a jury verdict for the University of Pennsylvania in a patent infringement suit involving nucleic acids that code for amyloid precursor protein with the Swedish mutation.
  • Defended a pharmaceutical client's patent rights against allegations of misappropriation and improper inventorship relating to novel forms of the enzyme arginine deiminase.
More »

Experience

  • Led a challenge of the agency's position regarding the availability of subpoenas in inter partes reexamination proceedings, including district court proceedings and an appeal to the Federal Circuit.
  • Secured a jury verdict for the University of Pennsylvania in a patent infringement suit involving nucleic acids that code for amyloid precursor protein with the Swedish mutation.
  • Defended a pharmaceutical client's patent rights against allegations of misappropriation and improper inventorship relating to novel forms of the enzyme arginine deiminase.
  • Obtained a finding of non-infringement for the client in a multiple-defendant litigation involving an assertion of four patents relating to the administration of hepatitis B vaccines.

Recognitions

  • Chambers USA: Intellectual Property in Pennsylvania (2007 to 2016)
  • The Legal 500 United States (2016)
    • Recommended in Intellectual Property: Patents – Prosecution (including re-examination and post-grant proceedings)
  • The Best Lawyers in America© (2010 to 2017)
    • Philadelphia: Litigation – Patent
    • Philadelphia: Patent Law
  • Martindale-Hubbell: AV Preeminent
  • Pennsylvania "Super Lawyer" (2010, 2013, 2014, 2016)

Memberships

  • Intellectual Property Owners, Inc.: Post Grant Patent Practice Committee

Services

Industries

Prior Positions

  • Woodcock Washburn LLP
    • Policy Committee
    • Finance Partner

Admissions

  • U.S. Court of Appeals, Federal Circuit
  • U.S. District Court, Eastern District of Pennsylvania
  • U.S. Patent and Trademark Office, Registration No. 33,307
  • Pennsylvania

Education

  • J.D., Boston College Law School, 1989, cum laude
  • M.S., Organic Chemistry, University of Pennsylvania, 1985
  • B.S., Chemistry, Georgetown University, 1983